← Evidence map

ArticleActa gastroenterologica Latinoamericana

From Intravenous to Subcutaneous Infliximab: the Same but Different? Real-World Evidence from a Tertiary Center.

María José Temido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41340960